Cargando…
Serum sclerostin is an independent predictor of mortality in hemodialysis patients
BACKGROUND: Sclerostin (Scl) has recently emerged as a novel marker of bone remodeling and vascular calcification. However, whether high circulating Scl is also a risk factor for death is not well established. The purpose of this study was to test whether serum Scl would be associated with mortality...
Autores principales: | Gonçalves, Flávia Letícia Carvalho, Elias, Rosilene M, dos Reis, Luciene M, Graciolli, Fabiana G, Zampieri, Fernando Godinho, Oliveira, Rodrigo B, Jorgetti, Vanda, Moysés, Rosa MA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265422/ https://www.ncbi.nlm.nih.gov/pubmed/25465028 http://dx.doi.org/10.1186/1471-2369-15-190 |
Ejemplares similares
-
Predictive Factors of One-Year Mortality in a Cohort of Patients Undergoing Urgent-Start Hemodialysis
por: Magalhães, Luciene P., et al.
Publicado: (2017) -
A prospective study of the influence of the skeleton on calcium mass transfer during hemodialysis
por: Goldenstein, Patricia Taschner, et al.
Publicado: (2018) -
The Protein-Independent Role of Phosphate in the Progression of Chronic Kidney Disease
por: Duayer, Irene Faria, et al.
Publicado: (2021) -
Effects of Dietary Phosphate on Adynamic Bone Disease in Rats with Chronic Kidney Disease – Role of Sclerostin?
por: Ferreira, Juliana C., et al.
Publicado: (2013) -
Parathyroidectomy Improves Restless Leg Syndrome in Patients on Hemodialysis
por: Santos, Roberto Sávio Silva, et al.
Publicado: (2016)